Tempus

DNA

MedTech

Tempus clocks FDA approval for 648-gene cancer test

The time has come for Tempus to secure its first premarket approval from the FDA.

Conor Hale May 8, 2023 8:05am

clinical trial data CRO contract research health

GSK pays Tempus $70M to expand access to patient data library

Oct 18, 2022 8:05am

a lab Tempus Chicago office

Tempus picks Lilly to bring genomic tests to NSCLC patients

Jun 9, 2022 1:04pm